Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Source Type and Protective Message on the Critical Evaluation of News Messages on Facebook: An Experimental Study in the Netherlands.

NCT05030883 is registered in ClinicalTrials.gov with Tilburg University as lead sponsor.

NCT NCT05030883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05030883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Source Type and Protective Message on the Critical Evaluation of News Messages on Facebook: An Experimental Study in the Netherlands.
Lead sponsor
Tilburg University
Phase
Not applicable
Overall status
Completed
Start date
May 10, 2019
Completion date
July 1, 2019
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disclosure of protective message